Pune, Maharashtra, India, September 12 2022 (Wiredrelease) Prudour Pvt. Ltd –:Vaccines are not just for kids. According to the Centers for Disease Control and Prevention (CDC), everyone six months and older should get a flu vaccine each year. And while most adults think of vaccines as something they got as children, many vaccines are recommended throughout adulthood to help protect against serious diseases like pneumonia, shingles, and whooping cough.
The global adult vaccines market is estimated to be valued at US$ 16.79 billion in 2022 and is expected to exhibit a CAGR of 7.3% during the forecast period (2022-2030).
The prevention of diseases in children and adults is possible through vaccination and immunization. Vaccines consist of biological suspensions which contain an agent that is similar in appearance to the disease-causing microorganisms. These vaccines are often made with inactivated microbes, toxic substances, or surface protein. Every year, thousands of people die from vaccine-preventable diseases. Adult immunization consists of administering licensed vaccines to patients who are 18 years or older and for medical indications. Vaccines can help protect you against deadly and serious infections like measles and flu. Inoculation for grown-ups that involves the distribution of authorized antibodies to patients, 18 years old and older, in order to detect clinical signs.
The market growth will be driven by a growing awareness of the importance of preventive medicine, and the development of vaccines to treat a variety of diseases. Other factors encouraging market growth are government support to combat the spread of vaccine-preventable conditions and innovative technology within the vaccine industry. The National Health Mission in India states that India is dedicated to measles elimination and rubella prevention. Measles Rubella vaccine (MR) was introduced into India via a campaign in 2017 in a gradual manner.
According to Centers for Disease Control and Prevention (CDC) (2019-2018), Vaccinated by disease:
45.00% of adults received the vaccine for Influenza
69.01% of adults receive a pneumococcal vaccination
49.00% of adolescents aged 13-17 received the HPV vaccination
Perfect your plan with our report here | request sample report @ https://market.us/report/adult-vaccine-market/request-sample/
Adult Vaccines Market Growth Drivers:
An increasing number of government initiatives are being taken to prevent certain diseases or epidemics
Different countries offer national immunization programs in order to spread vaccination awareness and to prevent the spread of fatal diseases.
Adult Vaccines Market Restrictions & Challenges:
The main factor that is hindering the growth of global adult vaccines markets include a large unvaccinated population for certain diseases such Tetanus or Diphtheria. According to the Centers of Disease Control & Prevention’s 2021 National Health Interview Survey (CDC 2021), 4 out of 5 respondents did not report for Tetanus Diphtheria or Pertussis vaccinations in the U.S. COVID-19 had an impact on adult vaccination coverage in 2020. Few adults might have seen Healthcare Professionals (HCPs), where vaccinations can be administered.
Key Market Players included in the report:
GlaxoSmithKline
Sanofi Pasteur
Merck
Novartis
Pfizer
BioCSL (Seqirus)
Protein Sciences
Global Adult Vaccines Market: Key Developments
In September 2021, the Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices released updated recommendations on the use of influenza vaccines for the 2021-2022 influenza season. Flucelvax Quadrivalent, a cell culture-based inactivated influenza vaccine, got approved in October 2021 by the U.S. Food and Drug Administration for use in the U.S.
Request For Covid-19 Impact Analysis On Adult Vaccine Market: https://market.us/request-covid-19/?report_id=62562
Key Market Segments
Type
Influenza
Cervical Cancer
Zoster Shingles
Pneumococcal
Meningococcal
MMRV
Hepatitis
DTP
Travel and Miscellaneous
Application
Hospitals
Medical Care Centers
Segmentation by Region
– North America (U.S. and Canada)
– Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
– Asia Pacific (China, India, South Korea, Indonesia, Australia, and Others)
– Latin America (Brazil, Mexico)
– Middle East and Africa
Frequently Asked Questions (FAQs)
Who are the most well-known players in the global Adult Vaccine Market? What is the role of emerging market players in expanding their presence in the Adult Vaccine Market? What are the biggest challenges for the Adult Vaccine Market? What are the key results of Porter’s five analysis SWOT and Porter? Which market is most covered by Adult Vaccine in terms of both market share, and size? What factors prevent the Adult Vaccine market growth from happening? What are the most important trends in the market today? How can I get company profiles of Adult Vaccine Market?
To turn massive challenges into meaningful change, Make an Inquiry of the report@ https://market.us/report/adult-vaccine-market/#inquiry
Explore More Report Here:
Global Adult and Adolescent Vaccines Market Trend | Demand and Import/Export Details up to 2031
Global Flu RNA Vaccines Market Size | Assessment, Key Factors and Challenges by 2031
Global Varicella Vaccine Market Share | Revenue And Structure Forecast To 2031
Global All Vaccine Market Growth | Demonstrates A Spectacular Growth By 2031
Pneumococcal Vaccine Market Global Sales Analysis Report: Growth Status, Revenue Expectation to 2031
Global Pertussis Vaccine Market Status | Business Growth and Development Factors by 2031
Media Contact
Company Name: Market.us (Powered By Prudour Pvt. Ltd.)
Global Business Development Teams – Market.us
Email: [email protected]
Phone: +1 718 618 4351
Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States
Connect with us at LinkedIn | Facebook | Twitter
This content has been published by Prudour Pvt. Ltd company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at [email protected].